Live Breaking News & Updates on Centre For Weight Management

Stay updated with breaking news from Centre for weight management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"Game changer" drug for treating obesity cuts body weight by 20% | UCL News - UCL – University College London


11 February 2021
One-third (35%) of people who took a new drug for treating obesity lost more than one-fifth (≥20%) of their total body weight, according to a major global study involving UCL researchers.
The findings from the large-scale international trial, published in the 
New England Journal for Medicine, are being hailed as a “game changer” for improving the health of people with obesity and could play a major part in helping the UK to reduce the impact of diseases, such as COVID-19.
The drug, semaglutide, works by hijacking the body’s own appetite regulating system in the brain leading to reduced hunger and calorie intake. ....

United States , United Kingdom , Rohit Mattoo , Rachel Batterham , Henry Killworth , Centre For Weight Management , European Medicines Agency , Centre For Obesity Research , Drug Administration , Novo Nordisk , National Institute Of Clinical Excellence , Professor John Wilding University Of Liverpool , New England Journal , Obesity Research , Weight Management , United Kingdom Chief Investigator , Professor John Wilding , Hammersmith Hospital , National Institute , Clinical Excellence , North America , Semaglutide Treatment Effect , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , மையம் க்கு எடை மேலாண்மை , மையம் க்கு உடல் பருமன் ஆராய்ச்சி ,

Semaglutide: "a significant advance in the treatment of obesity"


This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking I agree you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our Cookie Settings . Please view our Cookie Policy to learn more about the use of cookies on our website.
Manage your cookiesI agree
Cookie Settings
Cookie Settings
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this websit ....

United Kingdom , Rachel Batterham , John Wilding , United Kingdom National Institute Of Clinical Excellence , Centre For Weight Management , European Medicines Agency , Drug Administration , University College London Hospital , University Of Liverpool , Obesity Research , University College London , Weight Management , United Kingdom Chief Investigator , Professor John Wilding , Hammersmith Hospital , National Institute , Clinical Excellence , ஒன்றுபட்டது கிஂக்டம் , ஜான் காட்டு , ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் ஆஃப் மருத்துவ சிறப்பானது , மையம் க்கு எடை மேலாண்மை , பல்கலைக்கழகம் கல்லூரி லண்டன் மருத்துவமனை , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , உடல் பருமன் ஆராய்ச்சி , பல்கலைக்கழகம் கல்லூரி லண்டன் , எடை மேலாண்மை ,

New Drug Could Be A 'Game-Changer' In Fight Against Obesity: UK Study


New Drug Could Be A Game-Changer In Fight Against Obesity: UK Study
The drug, semaglutide, works by hijacking the body’s own appetite-regulating system in the brain leading to reduced hunger and calorie intake.
AP
Outlook Web Bureau
2021-02-11T22:46:49+05:30
New Drug Could Be A Game-Changer In Fight Against Obesity: UK Study
outlookindia.com
2021-02-11T22:50:56+05:30
The results of trials of a new drug have given new hopes to combat obesity successfully. The findings from a large-scale international trial are being hailed as a “game-changer” in the UK for improving the health of people with obesity.
The drug could even play a major part in helping reduce the impact of diseases such as COVID-19. ....

United Kingdom , Rachel Batterham , John Wilding , University College London , Centre For Obesity Research , Drug Administration , University Of Liverpool , United Kingdom National Institute Of Clinical Excellence , Centre For Weight Management , European Medicines Agency , Novo Nordisk , New England Journal , Obesity Research , United Kingdom Chief Investigator , Professor John Wilding , National Institute , Clinical Excellence , Obesity Drugs , Obesity Medicine , Uk Obesity , Obesity Symptoms , Obesity Problems , Semaglutide Obesity , ஒன்றுபட்டது கிஂக்டம் , ஜான் காட்டு , பல்கலைக்கழகம் கல்லூரி லண்டன் ,